Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.52 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.52 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 5/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | PTGES | O14684 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | RORC | P51449 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4962039 | 0.88 | MEN1 (0.52) | MEN1KMT2APOLBHPGDDUSP3 | |
| SCHEMBL6986224 | 0.85 | SMN1; SMN2 (0.55) | MEN1KMT2APOLBHPGDDUSP3 | |
| SCHEMBL3556091 | 0.84 | PTPN1 (0.58) | MEN1KMT2ATSHRTDP1ALDH1A1 | |
| SCHEMBL3858203 | 0.84 | ALDH1A1 (0.42) | MEN1KMT2APOLBHPGDDUSP3 | |
| SCHEMBL23909557 | 0.83 | ALDH1A1 (0.54) | MEN1KMT2APOLBHPGDDUSP3 | |
| SCHEMBL3855978 | 0.83 | TDP1 (0.57) | MEN1KMT2APOLBHPGDDUSP3 | |
| SCHEMBL7673918 | 0.83 | ALDH1A1 (0.53) | MEN1KMT2APOLBHPGDDUSP3 | |
| SCHEMBL17288756 | 0.81 | TSHR (0.46) | MEN1KMT2APOLBHPGDDUSP3 | |
| SCHEMBL26885154 | 0.79 | LMNA (0.56) | MEN1KMT2APOLBMAPTSMN1; SMN2 | |
| SCHEMBL9077610 | 0.77 | ALDH1A1 (0.44) | MEN1KMT2APOLBHPGDDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015013456-A1 | INDICATOR COMPOUNDS, POLYMERIZABLE DERIVATIVES THEREOF AND INFECTION INDICATING MEDICAL DEVICES COMPRISING THE SAME | INDICATOR SYSTEMS INTERNATIONAL, INC. (US) | 2015-01-29 | — | — | WO | disclosed |
| US-20140378503-A1 | ANTI-CANCER COMPOUNDS | NORTHWESTERN UNIVERSITY | 2014-12-25 | — | — | US | disclosed |
| US-8829025-B2 | Anti-cancer compounds | NORTHWESTERN UNIVERSITY (US) | 2014-09-09 | — | — | US | disclosed |
| EP-1871844-B1 | BUBBLE COMPOSITION WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2014-08-27 | — | — | EP | disclosed |
| US-20130225634-A1 | ANTI-CANCER COMPOUNDS | NORTHWESTERN UNIVERSITY (US) | 2013-08-29 | — | — | US | disclosed |
| US-8420665-B2 | Anti-cancer compounds | NORTHWESTERN UNIVERSITY (US) | 2013-04-16 | — | — | US | disclosed |
| US-20100303719-A1 | ANTI-CANCER COMPOUNDS | NORTHWESTERN UNIVERSITY (US) | 2010-12-02 | — | — | US | disclosed |
| WO-2009089537-A2 | ANTI-CANCER COMPOUNDS | NORTHWESTERN UNIVERSITY (US) | 2009-07-16 | — | — | WO | disclosed |
| EP-1871844-A2 | NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C Technologies LLC (US) | 2008-01-02 | — | — | EP | disclosed |
| WO-2007064345-A9 | HETEROCYCLIC-SUBSTITUTED BIS-1,8 NAPHTHALIMIDE COMPOUNDS, ANTIBODY DRUG CONJUGATES, AND METHODS OF USE | GENENTECH INC (US) | 2007-07-12 | — | — | WO | disclosed |
| WO-2007008389-A2 | USE OF COLOR CHANGING INDICATORS IN CONSUMER PRODUCTS | C2C TECHNOLOGIES LLC (US) | 2007-01-18 | — | — | WO | disclosed |
| US-20070010400-A1 | Use of color changing indicators in consumer products | C2C TECHNOLOGIES, LLC | 2007-01-11 | — | — | US | disclosed |
| US-20060257439-A1 | Cleansing compositions with color changing indicator | CRAYOLA LLC | 2006-11-16 | — | — | US | disclosed |
| US-20060236470-A1 | Novelty compositions with color changing indicator | CRAYOLA LLC | 2006-10-26 | — | — | US | disclosed |
| WO-2006105193-A2 | PERSONAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105261-A1 | CLEANSING COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105260-A1 | ORAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105191-A2 | NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| US-20060222675-A1 | Personal care compositions with color changing indicator | C2C TECHNOLOGIES, LLC | 2006-10-05 | — | — | US | disclosed |
| US-20060222601-A1 | Oral care compositions with color changing indicator | C2C TECHNOLOGIES, LLC | 2006-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060222675-A1 | Personal care compositions with color changing indicator | CUTA, POLR1C, TYR | MEN1 2817/4885KMT2A 3653/4885POLB 157/4885 |
| US-20140378503-A1 | ANTI-CANCER COMPOUNDS | TP53, MKI67, MYC | MEN1 988/4885KMT2A 1803/4885POLB 1443/4885 |
| US-20060257439-A1 | Cleansing compositions with color changing indicator | WASHC5, WASHC4, FHIT | MEN1 1113/4885KMT2A 3047/4885POLB 867/4885 |
| US-20100303719-A1 | ANTI-CANCER COMPOUNDS | TP53, MKI67, MYC | MEN1 988/4885KMT2A 1803/4885POLB 1443/4885 |
| US-20060222601-A1 | Oral care compositions with color changing indicator | CA9, CA7, TAS2R7 | MEN1 3449/4885KMT2A 2738/4885POLB 434/4885 |
| US-20070010400-A1 | Use of color changing indicators in consumer products | NQO2, CA4, CA7 | MEN1 3755/4885KMT2A 1465/4885POLB 2689/4885 |
| US-20130225634-A1 | ANTI-CANCER COMPOUNDS | TP53, MKI67, MYC | MEN1 988/4885KMT2A 1803/4885POLB 1443/4885 |
| US-20060236470-A1 | Novelty compositions with color changing indicator | MITF, CRABP2, SHH | MEN1 3006/4885KMT2A 1508/4885POLB 470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.